Perigon Wealth Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$375K Buy
4,799
+474
+11% +$37.1K 0.01% 765
2025
Q1
$313K Buy
4,325
+278
+7% +$20.1K 0.01% 799
2024
Q4
$283K Sell
4,047
-75
-2% -$5.24K 0.01% 842
2024
Q3
$272K Buy
4,122
+134
+3% +$8.84K 0.01% 826
2024
Q2
$368K Buy
3,988
+150
+4% +$13.9K 0.01% 620
2024
Q1
$367K Buy
3,838
+36
+0.9% +$3.44K 0.01% 622
2023
Q4
$290K Sell
3,802
-854
-18% -$65.1K 0.01% 667
2023
Q3
$323K Sell
4,656
-162
-3% -$11.2K 0.01% 561
2023
Q2
$454K Buy
4,818
+118
+3% +$11.1K 0.02% 481
2023
Q1
$389K Buy
4,700
+95
+2% +$7.86K 0.02% 456
2022
Q4
$344K Buy
4,605
+1,379
+43% +$103K 0.02% 492
2022
Q3
$267K Sell
3,226
-340
-10% -$28.1K 0.02% 454
2022
Q2
$339K Buy
3,566
+608
+21% +$57.8K 0.03% 399
2022
Q1
$348K Sell
2,958
-22
-0.7% -$2.59K 0.02% 428
2021
Q4
$386K Buy
2,980
+275
+10% +$35.6K 0.03% 396
2021
Q3
$306K Buy
2,705
+192
+8% +$21.7K 0.03% 412
2021
Q2
$260K Buy
2,513
+27
+1% +$2.79K 0.02% 436
2021
Q1
$208K Buy
+2,486
New +$208K 0.02% 467
2018
Q2
Sell
-1,434
Closed -$67K 355
2018
Q1
$67K Buy
+1,434
New +$67K 0.02% 278
2017
Q4
Sell
-1,434
Closed -$52K 627
2017
Q3
$52K Hold
1,434
0.02% 332
2017
Q2
$57K Sell
1,434
-279
-16% -$11.1K 0.01% 368
2017
Q1
$54K Buy
1,713
+87
+5% +$2.74K 0.01% 384
2016
Q4
$50K Buy
1,626
+582
+56% +$17.9K 0.01% 362
2016
Q3
$42K Hold
1,044
0.01% 330
2016
Q2
$35K Hold
1,044
0.01% 305
2016
Q1
$31K Buy
+1,044
New +$31K 0.01% 214